{"id":"https://openalex.org/W4379508779","doi":"https://doi.org/10.1007/s00228-023-03513-4","title":"A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor","display_name":"A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor","publication_year":2023,"publication_date":"2023-06-06","ids":{"openalex":"https://openalex.org/W4379508779","doi":"https://doi.org/10.1007/s00228-023-03513-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/37278823","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10243242"},"language":"en","primary_location":{"id":"doi:10.1007/s00228-023-03513-4","doi":"https://doi.org/10.1007/s00228-023-03513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00228-023-03513-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00228-023-03513-4.pdf","source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00228-023-03513-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022901371","display_name":"Terri L. Morton","orcid":"https://orcid.org/0000-0002-5004-8761","observed_orcids":["https://orcid.org/0000-0002-5004-8761"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terri L. Morton","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":"https://orcid.org/0000-0002-5004-8761","affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109985413","display_name":"Oscar L. Laskin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oscar L. Laskin","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040799420","display_name":"Diksha Kaushik","orcid":"https://orcid.org/0000-0002-8532-5992","observed_orcids":["https://orcid.org/0000-0002-8532-5992"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diksha Kaushik","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011215708","display_name":"Lucy Lee","orcid":"https://orcid.org/0000-0001-6975-8459","observed_orcids":["https://orcid.org/0000-0001-6975-8459"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucy Lee","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027918265","display_name":"Jiyuan Ma","orcid":"https://orcid.org/0000-0001-6538-4023","observed_orcids":["https://orcid.org/0000-0001-6538-4023","https://orcid.org/0009-0000-8185-1410"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiyuan Ma","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092096077","display_name":"Cristian M. Bar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristian M. Bar","raw_affiliation_strings":["Syneos Health, Quebec, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syneos Health, Quebec, QC, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108460491","display_name":"Allan Kristensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allan Kristensen","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108871324","display_name":"Kylie O\u2019Keefe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kylie O\u2019Keefe","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019100820","display_name":"Lee Golden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee Golden","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103406622","display_name":"Matthew B. Klein","orcid":"https://orcid.org/0000-0002-8697-1769","observed_orcids":["https://orcid.org/0000-0002-8697-1769"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Klein","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056763549","display_name":"Ronald Kong","orcid":"https://orcid.org/0000-0002-4692-7499","observed_orcids":["https://orcid.org/0000-0002-4692-7499"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ronald Kong","raw_affiliation_strings":["PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA. rkong@ptcbio.com","PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA"],"raw_orcid":"https://orcid.org/0000-0002-4692-7499","affiliations":[{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA. rkong@ptcbio.com","institution_ids":["https://openalex.org/I4210134724"]},{"raw_affiliation_string":"PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA","institution_ids":["https://openalex.org/I4210134724"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5056763549"],"corresponding_institution_ids":["https://openalex.org/I4210134724"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":0.4579,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.50609481,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"79","issue":"8","first_page":"1073","last_page":"1080"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dextromethorphan","display_name":"dextromethorphan","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cyp2d6-inhibition","display_name":"CYP2D6 inhibition","score":0.9520000219345093},{"id":"https://openalex.org/keywords/dihydroorotate-dehydrogenase-inhibitors","display_name":"dihydroorotate dehydrogenase inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8949999809265137},{"id":"https://openalex.org/keywords/covid-19-treatment","display_name":"COVID-19 treatment","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dextrorphan","display_name":"dextrorphan","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7329999804496765},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.43299999833106995},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.367000013589859},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2781245242","wikidata":"https://www.wikidata.org/wiki/Q407781","display_name":"Dextromethorphan","level":2,"score":0.9930254220962524},{"id":"https://openalex.org/C2779591118","wikidata":"https://www.wikidata.org/wiki/Q659468","display_name":"Dextrorphan","level":3,"score":0.9835509061813354},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7925159931182861},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7384926676750183},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6089552044868469},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.5429823398590088},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5085276365280151},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5066223740577698},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4858848452568054},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4851158857345581},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4377685785293579},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32720375061035156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18774142861366272},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.15350699424743652},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0810231864452362}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000090722","descriptor_name":"Dihydroorotate Dehydrogenase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003915","descriptor_name":"Dextromethorphan","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003917","descriptor_name":"Dextrorphan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00228-023-03513-4","doi":"https://doi.org/10.1007/s00228-023-03513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00228-023-03513-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00228-023-03513-4.pdf","source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10243242","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10243242","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10243242/pdf/228_2023_Article_3513.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:37278823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37278823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00228-023-03513-4","doi":"https://doi.org/10.1007/s00228-023-03513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00228-023-03513-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00228-023-03513-4.pdf","source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320314126","display_name":"PTC Therapeutics","ror":"https://ror.org/03jz67a83"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379508779.pdf","grobid_xml":"https://content.openalex.org/works/W4379508779.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1601438838","https://openalex.org/W2000782600","https://openalex.org/W2121102924","https://openalex.org/W2166544699","https://openalex.org/W2257562765","https://openalex.org/W2343295103","https://openalex.org/W2618083329","https://openalex.org/W2738657322","https://openalex.org/W2897748008","https://openalex.org/W2922901737","https://openalex.org/W3047125225","https://openalex.org/W3108974439","https://openalex.org/W3111005424","https://openalex.org/W3217358102","https://openalex.org/W4205266858"],"related_works":["https://openalex.org/W4327892890","https://openalex.org/W3217358102","https://openalex.org/W3108974439","https://openalex.org/W2521911750","https://openalex.org/W2051877339","https://openalex.org/W3087127729","https://openalex.org/W3150782232","https://openalex.org/W2000782600","https://openalex.org/W2791033194","https://openalex.org/W2287323437"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"A":[2],"therapeutic":[3],"agent":[4],"that":[5],"targets":[6],"both":[7],"viral":[8],"replication":[9],"and":[10,49,85,97,102,192,211,231,242],"the":[11,59,164],"hyper-reactive":[12],"immune":[13],"response":[14],"would":[15],"offer":[16],"a":[17,44,86,122,252],"highly":[18],"desirable":[19],"treatment":[20,258],"for":[21,189,198,235],"severe":[22,267],"acute":[23],"respiratory":[24],"syndrome":[25],"corona":[26],"virus":[27],"2":[28],"(SARS-CoV-2,":[29],"coronavirus":[30],"disease":[31],"2019,":[32],"COVID-19)":[33],"management.":[34],"Emvododstat":[35,248],"(PTC299;":[36],"4-chlorophenyl":[37],"6-chloro-1-[4-methoxyphenyl]-1,3,":[38],"4,9-tetrahydro-2H-pyrido[3,4-b]indole-2-carboxylate)":[39],"was":[40,68,74,146],"found":[41,222],"to":[42,57,70,177,186,195,223,250,265],"be":[43,224,251,266],"potent":[45],"inhibitor":[46,76],"of":[47,54,61,77,116,134,203],"immunomodulatory":[48],"inflammation-related":[50],"processes":[51],"by":[52,93,121],"inhibition":[53],"dihydroorotate":[55],"dehydrogenase":[56],"reduce":[58],"severity":[60],"SARS-CoV-2":[62],"infections":[63],"This":[64],"drug":[65],"interaction":[66],"study":[67],"performed":[69],"determine":[71],"if":[72],"emvododstat":[73,84,104,137],"an":[75,113,131],"CYP2D6.":[78],"Methods":[79],"Potential":[80],"drug-drug":[81],"interactions":[82],"between":[83],"CYP2D6":[87,254],"probe":[88],"substrate":[89],"(dextromethorphan)":[90],"were":[91,208,221,263],"investigated":[92],"measuring":[94],"plasma":[95,153,167],"dextromethorphan":[96,119,145,154,168,206],"metabolite":[98,159],"(dextrorphan)":[99,161],"concentrations":[100,155],"before":[101,210],"after":[103,212],"administration.":[105],"On":[106,126],"day":[107,127],"1,":[108],"18":[109],"healthy":[110],"subjects":[111,129],"received":[112,130],"oral":[114,132],"dose":[115,133],"30":[117,143],"mg":[118,136,144],"followed":[120],"4-day":[123],"washout":[124],"period.":[125],"5,":[128],"250":[135],"with":[138,151],"food.":[139],"Two":[140],"hours":[141],"later,":[142],"administered.":[147],"Results":[148],"When":[149,205],"given":[150],"emvododstat,":[152,213],"increased":[156,174,183],"substantially,":[157],"while":[158],"levels":[160],"remained":[162],"essentially":[163],"same.":[165],"Maximum":[166],"concentration":[169],"(":[170],"C":[171,236],"max":[172,237],")":[173],"from":[175,184,193],"2006":[176],"5847":[178],"pg/mL.":[179],"Dextromethorphan":[180],"exposure":[181],"(AUC)":[182],"18,829":[185],"157,400":[187],"h\u00b7pg/mL":[188,197],"AUC":[190,199,239,243],"0-last":[191,240],"21,585":[194],"362,107":[196],"0-inf":[200,244],"following":[201],"administration":[202],"emvododstat.":[204],"parameters":[207],"compared":[209],"least":[214],"squares":[215],"mean":[216],"ratios":[217],"(90%":[218],"confidence":[219],"interval)":[220],"2.9":[225],"(2.2,":[226],"3.8),":[227],"8.4":[228],"(6.1,":[229],"11.5),":[230],"14.9":[232],"(10.0,":[233],"22.1)":[234],",":[238,241,245],"respectively.":[246],"Conclusion":[247],"appears":[249],"strong":[253],"inhibitor.":[255],"No":[256],"drug-related":[257],"emergent":[259],"adverse":[260],"effects":[261],"(TEAEs)":[262],"considered":[264],"or":[268],"serious.":[269],"Trial":[270],"registration":[271],"EudraCT":[272],"2021-004626-29,":[273],"11":[274],"May":[275],"2021.":[276]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-06-07T00:00:00"}